Garbin Juliana Rodrigues Tovar, Leite Franciéle Marabotti Costa, Santos Ana Paula Brioschi Dos, Dell'Antonio Larissa Soares, Dell'Antonio Cristiano Soares da Silva, Lopes-Júnior Luís Carlos
Instituto Federal do Espírito Santo/IFES, Espírito Santo, Brazil.
Graduate Program in Public Health - PPGSC/UFES, Vitória, Espírito Santo, Brazil.
PLoS One. 2025 Sep 9;20(9):e0332128. doi: 10.1371/journal.pone.0332128. eCollection 2025.
A comprehensive understanding of the factors influencing the epidemiological dynamics of COVID-19 across the pandemic waves-particularly in terms of disease severity and mortality-is critical for optimizing healthcare services and prioritizing high-risk populations. Here we aim to analyze the factors associated with short-term and prolonged hospitalization for COVID-19 during the first three pandemic waves. We conducted a retrospective observational study using data from individuals reported in the e-SUS-VS system who were hospitalized for COVID-19 in a state in a southeast state of Brazil. Hospitalization duration was classified as short or prolonged based on a 7-day cutoff, corresponding to the median length of hospital stay during the second pandemic wave. Bivariate analyses were performed using the chi-square test for heterogeneity. Logistic regression models were used to estimate odds ratios (ORs) and their respective 95% confidence intervals (CIs), with statistical significance set at 5%. When analyzing hospitalization duration across the three waves, we found that 51.1% (95%CI: 49.3-53) of hospitalizations in the first wave were prolonged. In contrast, short-duration hospitalizations predominated in the second (54.7%; 95% CI: 52.4-57.0) and third (51.7%; 95% CI: 50.2-53.2) waves. Factors associated with prolonged hospitalization varied by wave. During the first wave, older adults (≥60 years) (OR=1.67; 95%CI: 1.35-2.06), individuals with ≥10 symptoms (OR=2.03; 95%CI: 1.04-3.94), obese individuals (OR=2.0; 95%CI: 1.53-2.74), and those with ≥2 comorbidities (OR=2.22; 95%CI: 1.71-2.89) were more likely to experience prolonged hospitalization. In the second wave, he likelihood of extended hospital stays was higher among individuals aged ≥60 years (OR=2.04; 95%CI: 1.58-2.62) and those with ≥2 comorbidities (OR=1.77; 95%CI: 1.29-2.41). In the third wave, prolonged hospitalization was more frequent among older adults (OR=1.89; 95%CI: 1.65-2.17,), individuals with 5-9 symptoms (OR=1.52; 95%CI: 1.20-1.92), obese individuals (OR=2.2; 95%CI: 1.78-2.73), and those with comorbidities (OR=1.45; 95%CI: 1.22-1.72 and OR=2.0; 95%CI: 1.69-2.45). In conclusion, we identified variations in hospitalization patterns across the pandemic waves, although the differences were relatively subtle. These variations likely reflect gradual shifts in the risk factors associated with prolonged hospital stays. Our findings highlight t the importance of implementing targeted public health interventions, particularly those designed to reduce disease severity and improve clinical outcomes among vulnerable populations at greater risk of extended hospitalization.
全面了解在疫情各波次中影响新冠病毒流行病学动态的因素,尤其是在疾病严重程度和死亡率方面,对于优化医疗服务以及确定高危人群的优先次序至关重要。在此,我们旨在分析在疫情前三波中与新冠病毒短期和长期住院相关的因素。我们利用电子SUS - VS系统报告的在巴西东南部某州因新冠病毒住院的个人数据进行了一项回顾性观察研究。根据7天的截断值将住院时间分为短期或长期,该截断值对应第二波疫情期间的住院中位时长。使用卡方检验进行异质性双变量分析。逻辑回归模型用于估计比值比(OR)及其各自的95%置信区间(CI),设定统计学显著性水平为5%。在分析三波疫情期间的住院时长时,我们发现第一波疫情中有51.1%(95%CI:49.3 - 53)的住院时间延长。相比之下,第二波(54.7%;95%CI:52.4 - 57.0)和第三波(51.7%;95%CI:50.2 - 53.2)疫情中短期住院占主导。与长期住院相关的因素因波次而异。在第一波疫情期间,老年人(≥60岁)(OR = 1.67;95%CI:1.35 - 2.06)、有≥10种症状的个体(OR = 2.03;95%CI:1.04 - 3.94)、肥胖个体(OR = 2.0;95%CI:1.53 - 2.74)以及有≥2种合并症的个体(OR = 2.22;95%CI:1.71 - 2.89)更有可能经历较长时间的住院。在第二波疫情中,≥60岁的个体(OR = 2.04;95%CI:1.58 - 2.62)和有≥2种合并症的个体(OR = 1.77;95%CI:1.29 - 2.41)延长住院的可能性更高。在第三波疫情中,老年人(OR = 1.89;95%CI:1.65 - 2.17)、有5 - 9种症状的个体(OR = 1.52;95%CI:1.20 - 1.92)、肥胖个体(OR = 2.2;95%CI:1.78 - 2.73)以及有合并症的个体(OR = 1.45;95%CI:1.22 - 1.72和OR = 2.0;95%CI:1.69 - 2.45)中较长时间住院更为常见。总之,我们确定了疫情各波次住院模式的差异,尽管差异相对细微。这些差异可能反映了与延长住院时间相关的危险因素的逐渐变化。我们的研究结果凸显了实施有针对性的公共卫生干预措施的重要性,特别是那些旨在降低疾病严重程度并改善住院时间延长风险较高的脆弱人群临床结局的措施。